Conavi Medical Corp. CNVI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 611.60K | 563.20K | 508.80K | 6.52M | 6.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 611.60K | 563.20K | 508.80K | 6.52M | 6.61M |
| Cost of Revenue | 24.00K | 24.70K | -35.90K | 1.07M | 1.37M |
| Gross Profit | 587.60K | 538.50K | 544.70K | 5.45M | 5.23M |
| SG&A Expenses | 5.85M | 5.44M | 4.91M | 4.39M | 4.54M |
| Depreciation & Amortization | 611.30K | 557.20K | 565.40K | 581.30K | 612.10K |
| Other Operating Expenses | 242.20K | 242.20K | 267.00K | 177.30K | 236.10K |
| Total Operating Expenses | 15.95M | 14.63M | 15.00M | 17.13M | 18.09M |
| Operating Income | -15.34M | -14.06M | -14.49M | -10.61M | -11.48M |
| Income Before Tax | -14.94M | -12.94M | -11.63M | -14.71M | -21.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.94 | -12.94 | -11.63 | -14.71 | -21.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.94M | -12.94M | -11.63M | -14.71M | -21.57M |
| EBIT | -15.34M | -14.06M | -14.49M | -10.61M | -11.48M |
| EBITDA | -14.94M | -13.72M | -14.13M | -10.23M | -11.12M |
| EPS Basic | -0.17 | -0.16 | -0.18 | -0.28 | -2.13 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.11 | -0.12 | -0.78 |
| EPS Diluted | -0.17 | -0.16 | -0.18 | -0.28 | -2.13 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.11 | -0.12 | -0.78 |
| Average Basic Shares Outstanding | 357.32M | 322.37M | 266.73M | 230.09M | 159.06M |
| Average Diluted Shares Outstanding | 357.32M | 322.37M | 266.73M | 230.09M | 159.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |